Alzamend Neuro, Inc. (ALZN)
Stock Price: $4.42 USD
-0.49 (-9.98%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed
Income Statement (Annual)
Numbers in millions USD. Fiscal year is May - April.
| Year | 2020 | 2019 | |
|---|---|---|---|
| Revenue | - | - | |
| Selling, General & Admin | 3.35 | 1.31 | |
| Research & Development | 1.07 | 3.70 | |
| Operating Expenses | 4.42 | 5.01 | |
| Operating Income | -4.42 | -5.01 | |
| Other Expense / Income | -0.01 | -0.15 | |
| Pretax Income | -4.41 | -4.86 | |
| Net Income | -4.41 | -4.86 | |
| Shares Outstanding (Basic) | 71.25 | 58.84 | |
| Shares Outstanding (Diluted) | 71.25 | 58.84 | |
| Shares Change | 21.09% | - | |
| EPS (Basic) | -0.06 | -0.08 | |
| EPS (Diluted) | -0.06 | -0.08 | |
| Free Cash Flow Per Share | -0.03 | -0.02 | |
| EBITDA | -4.41 | -4.86 | |
| EBIT | -4.41 | -4.86 |